Synapse - Bone Marrow Transplant

Results (2971)

Long-term sustained minimal residual disease (MRD) negativity in patients with multiple myeloma treated with continuous lenalidomide maintenance therapy: A clinical and correlative phase 2 study

Meeting Abstract

Diamond, B.; Korde, N.; Lesokhin, A. M.; Smith, E. L.; Shah, U. A.; Mailankody, S.; Hultcrantz, M.; Hassoun, H.; Lu, S. X.; Tan, C.; more...
Blood (2020)

Fulltext@MSK | Save

KarMMa-3: A phase 3 study of idecabtagene vicleucel (ide-cel, bb2121), a BCMA-directed CAR T cell therapy vs standard regimens in relapsed and refractory multiple myeloma

Meeting Abstract

Delforge, M.; Baz, R. C.; Cavo, M.; Callander, N. S.; Ghobadi, A.; Rodriguez-Otero, P.; Mateos, M. V.; Massaro, M.; Ding, L.; Patel, P.; more...
Blood (2020)

Fulltext@MSK | Save

TCR repertoires in graft-versus-host-disease (GVHD)-target tissues reveals tissue specificity of the alloimmune response

Meeting Abstract

DeWolf, S.; Nichols, K.; Nguyen, C. L.; Giardina, P. A.; Slingerland, J. B.; Elias, H.; Kappangantula, R.; Baez, P.; Murali, R.; Hayashi, A.; more...
Blood (2020)

Fulltext@MSK | Save

A single-arm, open-label phase 1 study of itacitinib (ITA) with calcineurin inhibitor (CNI)-based interventions for prophylaxis of graft-versus-host disease (GVHD; GRAVITAS-119)

Meeting Abstract

Choe, H.; Shah, N. N.; Chevallier, P.; Rubio, M. T.; Schroeder, M. A.; Hardy, N. M.; Stiff, P. J.; Solano, C.; Yakoub-Agha, I.; Gutman, J. A.; more...
Blood (2020)

Fulltext@MSK | Save

Safety and efficacy of maintenance treatment following allogeneic hematopoietic cell transplant in acute myeloid leukemia and myelodysplastic syndrome - A systematic review and meta-analysis

Meeting Abstract

Bewersdorf, J. P.; Tallman, M. S.; Cho, C.; Zeidan, A. M.; Stahl, M.
Blood (2020)

Fulltext@MSK | Save

Preliminary results of the first-in-human study of NEXI-001, a multi-antigen specific CD8+ T cell product, in acute myeloid leukemia (AML) patients with relapsed disease after allogeneic hematopoietic cell transplantation (allo-HSCT) demonstrate early signs of safety, tolerability and robust immune responses

Meeting Abstract

Al Malki, M. M.; Perales, M. A.; Modi, M. D.; Vasu, S.; Nelson, M.; Bui, D.; Kim, S.; Wang, R. P.; Lu, E.; Oelke, M.; more...
Blood (2020)

Fulltext@MSK | Save

Aumento del uso y del coste de recursos sanitarios en pacientes hospitalizados seropositivos para CMV receptores de trasplantes alogénicos de células madre hematopoyéticas bajo tratamiento preventivo

Meeting Abstract

Fernandez-Cuesta, I.; Fang, J.; Zavras, P. D.; Su, Y.; Raval, A.; Tang, Y.; Stern, A.; Perales, M. A.; Giralt, S.; Papanicolaou, G.
Haematologica (2020)

Fulltext@MSK | Save

Incremental value of global longitudinal strain for predicting survival in patients with advanced AL amyloidosis

Journal Article

Chuy, K. L.; Drill, E.; Yang, J. C.; Landau, H.; Hassoun, H.; Nahhas, O.; Chen, C. L.; Yu, A. F.; Steingart, R. M.; Liu, J. E.
JACC: CardioOncology (2020)

Fulltext@MSK | Save

Graft vs. host disease leads to elimination of tissue-resident innate lymphoid cells following experimental and clinical allogeneic transplantation

Meeting Abstract

Vinci, P.; Garcia-Martinez, E.; O'Connor, M. H.; Egorova, A.; Kuttiyara, J.; Arnhold, V.; Ponce, D. M.; Hanash, A. M.
Journal of Immunology (2020)

Fulltext@MSK | Save

Allogeneic hematopoietic cell transplantation (alloHCT) for patients over 65 years old is not associated with worse symptoms/function than younger patients - A Center for International Blood and Marrow Transplant Research (CIBMTR) study

Meeting Abstract

Shaw, B.; Brazauskas, R.; Burns, L. J.; Mattila, D.; Musseter, A.; Chen, M.; Vasu, S.; Pidala, J.; Muffly, L.; Uberti, J.; more...
Quality of Life Research (2020)

Fulltext@MSK | Save